February 27, 2018
Otsuka Pharmaceutical Co., Ltd.
New EQUELLE Gelée Supports the Fundamentals of Women's Beauty and Health
- New from the trusted EQUELLE brand, a flavorful, convenient equol supplement -
- A jelly-type beverage containing soy product equol, collagen, calcium and other ingredients, EQUELLE Gelée will be launched on April 3, 2018.
- New addition to the EQUELLE brand supports women's beauty and health from the inside out
Otsuka Pharmaceutical Co., Ltd. has announced the April 3, 2018 nationwide Japan launch of EQUELLE Gelée, a new addition to the EQUELLE brand of dietary supplements that contributes to women's health and beauty.
EQUELLE Gelée was developed to support the fundamentals of women's beauty and health. In addition to soy metabolite equol, each pouch of refreshing, orange-flavored EQUELLE Gelée contains collagen, calcium, and other beneficial ingredients to support women's beauty and health from the inside out.
About the EQUELLE Brand
Amidst increases in healthy life expectancy and expanded opportunities for participation in society, women are subject to a range of emotional and physical changes at certain life stages. Over many years of research into the benefits of soy, Otsuka Pharmaceutical discovered the close connection between soy metabolite equol and women's health. Following extensive research to confirm safety and efficacy, EQUELLE (tablet form) was launched in 2014 as a supplement containing equol produced by fermenting soy with lactic acid bacterium to support women's health and beauty during life stage transitions.
The launch of new EQUELLE Gelée offers a flavorful, convenient way to consume equol in a wide range of daily scenarios. The growing line of EQUELLE products aims to support women's health and beauty and enhance quality of life.
Ingreadients and Nutrition Facts
Otsuka Pharmaceutical Equol-related Research and Development and Public Awareness Activities
Over many years of soy research, Otsuka Pharmaceutical has focused on the relationship between equol and the emotional and physical changes affecting women during the menopausal transition. Research into equol was initiated at the Saga Nutraceuticals Research Institute in 1996, and in 2002 Lactococcus 20-92, the lactic acid bacterium which produces equol, was successfully isolated. Both the Pharmaceuticals Business Division and the Nutraceuticals Business Division have conducted clinical studies in both Japan and the US using equol produced by fermenting soy germ with this lactic acid bacterium (naturally occurring as S-equol), resulting in numerous reports detailing the health benefits of equol.
Based on 18 years of research in Japan and overseas, EQUELLE was launched in April 2014 as a convenient way to consume equol on a daily basis.
In Japan, staff with expert knowledge stationed nationwide are supported by doctors and healthcare professionals in communicating the importance of proactive self care to women who are starting to experience changes associated with menopause, aiming to contribute to women's heath and enhance their quality of life.
Information in this news release was current as of the original release date.